Individuals with Parkinson’s disease (PD) are at risk for increased medication mismanagement, which can lead to worse clinical outcomes. However, the nature of the errors (i.e., undertaking or overtaking medications) contributing to mismanagement and their relationship to cognition in PD is unknown. Therefore, this study sought to examine errors committed on the Medication Management Ability Assessment (MMAA) between PD participants with normal cognition (PD-NC) or mild cognitive impairment (PD-MCI) relative to healthy adults (HA).

中文翻译：

---

帕金森病药物管理绩效：检查过程错误

帕金森病 (PD) 患者面临药物管理不善增加的风险，这可能导致更差的临床结果。然而，导致管理不善的错误（即服用或过量服用药物）的性质及其与 PD 认知的关系尚不清楚。因此，本研究旨在检查认知正常 (PD-NC) 或轻度认知障碍 (PD-MCI) 的 PD 参与者相对于健康成人 (HA) 在药物管理能力评估 (MMAA) 中所犯的错误。